piracetam has been researched along with Bacterial Disease in 1 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Excerpt | Relevance | Reference |
---|---|---|
" Clinicians should be mindful that standard dosing of these agents may not achieve typical target concentrations in this clinical scenario." | 1.39 | Augmented renal clearance of vancomycin and levetiracetam in a traumatic brain injury patient. ( Arora, S; Cook, AM; Davis, J; Pittman, T, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cook, AM | 1 |
Arora, S | 1 |
Davis, J | 1 |
Pittman, T | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Relation Between Renal Resistive Index, Glomerular Hyperfiltration and Hyperdynamic Circulation in Critically Ill Patients With Trauma or Sepsis.[NCT02560402] | 40 participants (Actual) | Observational | 2015-08-31 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 other study available for piracetam and Bacterial Disease
Article | Year |
---|---|
Augmented renal clearance of vancomycin and levetiracetam in a traumatic brain injury patient.
Topics: Anti-Bacterial Agents; Anticonvulsants; Bacterial Infections; Brain Injuries; Drug Monitoring; Femal | 2013 |